Prognostic role of chromosomal translocations (CT) in myelodysplasia (MDS) was retrospectively analyzed in 77 patients from GROM-L registry. Forty (51.9%) balanced, 28 (36.4%) unbalanced and 9 (11.7%) concomitant balanced and unbalanced CT were identified. Five-year overall survival (OS) of the entire cohort was 34.5% (CI 95% 22.546.5). Five-year OS of patients with unbalanced CT was significantly shorter than that of patients carrying balanced CT [22.3% (CI 95% 4.040.6) vs 44.0% (CI 95% 26.761.3) (p¼0.042)]. Five-year OS of patients with CT included in complex karyotype (CK) was significantly shorter than that of patients with isolated CT or CT with another abnormality [5.5% (CI 95% 015.7) vs 42.9% (CI 95% 21.364.5) and vs 4% (CI 9...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Abstract. The karyotype represents one of the main cornerstones for the International Prognostic Sco...
The impact of clinical parameters, International Prognostic Scoring System (IPSS) scores/cytogenetic...
Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall su...
Myelodysplastic Syndromes (MDS) are a heterogeneous group of hematological diseases characterized by...
This study aimed to determine the incidence/prognostic impact of TP53 mutation in 318 myelodysplasti...
The acquisition of additional chromosomal abnormalities, clonal evolution (CE), during the course of...
In a study of 56 consecutive adult patients with de novo myelodysplastic syndromes (MDS). all cases ...
Risk stratification is critical in the care of patients with myelodysplastic syndromes (MDS). Approx...
Risk stratification is critical in the care of patients with myelodysplastic syndromes (MDS). Approx...
Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall su...
Complex chromosomal aberrations occurs are described in approximately 20 % of patients with myelodys...
Abstract In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome ...
The deletion (5q) karyotype (del [5q]) in patients with myelodysplastic syndrome (MDS) is the most c...
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal disorders of haematopoiet...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Abstract. The karyotype represents one of the main cornerstones for the International Prognostic Sco...
The impact of clinical parameters, International Prognostic Scoring System (IPSS) scores/cytogenetic...
Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall su...
Myelodysplastic Syndromes (MDS) are a heterogeneous group of hematological diseases characterized by...
This study aimed to determine the incidence/prognostic impact of TP53 mutation in 318 myelodysplasti...
The acquisition of additional chromosomal abnormalities, clonal evolution (CE), during the course of...
In a study of 56 consecutive adult patients with de novo myelodysplastic syndromes (MDS). all cases ...
Risk stratification is critical in the care of patients with myelodysplastic syndromes (MDS). Approx...
Risk stratification is critical in the care of patients with myelodysplastic syndromes (MDS). Approx...
Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall su...
Complex chromosomal aberrations occurs are described in approximately 20 % of patients with myelodys...
Abstract In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome ...
The deletion (5q) karyotype (del [5q]) in patients with myelodysplastic syndrome (MDS) is the most c...
Myelodysplastic syndromes (MDS) constitute a heterogeneous group of clonal disorders of haematopoiet...
We analyzed cytogenetically 105 patients with hypocellular primary MDS and their clinical implicatio...
Abstract. The karyotype represents one of the main cornerstones for the International Prognostic Sco...
The impact of clinical parameters, International Prognostic Scoring System (IPSS) scores/cytogenetic...